Hot line - First-in-man interventions for valvular heart disease

Session comprising selected EuroPCR 2015 late-breaking trial submissions

Presentations available when logged in:

  • Advance in percutaneous tricuspid valve repair: initial outcomes from the first-in-human multicentre study
  • 30-day safety and performance results from a first-in-man trial of a low-profile transapical delivery system for transcatheter implantation of an a...
  • 30-day VARC-2 and performance data of a new self-expanding transcatheter aortic valve
  • 1-year outcome of the COSTA trial: first-in-human implantation of a dry, pre-mounted low-profile TAVI valve
  • Septal sinus shortening for the treatment of functional mitral regurgitation: 6-month results